SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Shrimp Army

$SHRIMPS is gaining momentum as part of a broader trend of ocean-themed meme coins circulating on social media. The community is actively debating the coin's potential for rapid gains, with some participants viewing it as a high-risk, short-term play while others express skepticism regarding the long-term viability of the project.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention as a high-concentration proxy trade for major upcoming IPOs, particularly SpaceX and Anthropic. Investors are actively debating the fund's NAV premium and the potential for a massive price surge driven by pre-IPO hype and the fund's unique position in private tech unicorns.

PRIME is the native token of the Echelon Prime Foundation, a Web3 ecosystem advancing the next generation of gaming. Echelon creates and distributes tools to encourage innovation in, and promote the growth of, novel gaming models and economies. The first game to adopt and utilize PRIME is Parallel, a sci-fi trading card game.

Echelon Prime

Echelon Prime is capturing investor attention as the community anticipates a significant breakout, with many bulls actively loading up on dips while speculating on long-term utility in the Web3 gaming and AI sectors. Traders are closely monitoring technical support levels and volume patterns, with much of the discussion focused on the potential for a rally despite recent market volatility.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is currently trending due to a contentious short report from Culper Research that alleges the company is engaged in channel stuffing and misleading financial reporting. While the stock has faced significant downward volatility, a vocal community of long-term investors is actively pushing back against the report, labeling it a manipulative hit piece and rallying around management's history of hitting financial targets, share buybacks, and robust growth forecasts.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure amid broader market uncertainty, compounded by a legal setback in a social media harm lawsuit and growing investor anxiety over massive capital expenditures in AI. The community is actively debating the company's valuation, questioning its heavy spending on the Reality Labs division, and speculating on the potential for upcoming layoffs to improve operational efficiency.

Direxion Shares ETF Trust - Direxion Daily Regional Banks Bull 3X ETF

Direxion Daily Regional Banks Bull 3X Shares

Investors are actively trading DPST as a leveraged play on the financial sector's rebound, with the community focused on scalping short-term price moves driven by volatile rate cut expectations and broader macroeconomic shifts. Sentiment remains polarized, as some traders utilize the volatility to capture gains while others express caution regarding the ETF's inherent decay and the potential for a reversal in regional bank performance.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Amarin Corp (AMRN) is trending due to the Supreme Court's upcoming conference on January 9, 2026, to decide whether to hear the company's patent infringement case against Hikma, a pivotal moment for its U.S. IP protection. The community is actively debating the potential implications of a Supreme Court ruling on 'skinny label' usage, alongside ongoing discussions about the company's path to profitability and speculation surrounding a potential acquisition following the appointment of a financial advisor.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics is experiencing a surge in investor interest and volatility driven by its strategic expansion into the healthcare sector through the acquisition of Diligent Robotics and continued deployments alongside major delivery platforms. The community remains highly active in debating the company's long-term growth potential and unit economics, with many monitoring short interest and technical breakouts as the stock attempts to sustain momentum following its presence at industry-wide technology showcases.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently seeing significant community interest ahead of a major data presentation at the AAD conference, where long-term results through Week 40 for their sonelokimab program are expected to be unveiled. Investors are closely tracking these upcoming results and rumored buyout interest from pharmaceutical giants, as the community debates whether the trial data will solidify the asset as a best-in-class treatment and trigger a major revaluation.

United States Commodity Funds LLC - United States Natural Gas Fund

United States Natural Gas Fund, LP

United States Natural Gas Fund (UNG) is trending as traders react to extreme winter weather, significant supply draws, and escalating geopolitical tensions that are fueling high volatility in the natural gas market. Community members are actively debating the sustainability of these price swings, with many traders using leveraged ETFs like BOIL and KOLD to capitalize on the rapid shifts in weather-driven demand and infrastructure constraints.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

KADENSA CAPITAL Ltd Takes Position in Ambiq Micro, Inc. $AMBQ

KADENSA CAPITAL Ltd purchased a new stake in shares of Ambiq Micro, Inc. (NYSE:AMBQ - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The...

Fortress Investment Group LLC Buys Shares of 150,000 Ambiq Micro, Inc. $AMBQ

Fortress Investment Group LLC purchased a new position in Ambiq Micro, Inc. (NYSE:AMBQ - Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange...

New Strong Sell Stocks for March 16th

AMBQ, ATHM and COHU have been added to the Zacks Rank #5 (Strong Sell) List on March 16, 2026.

Ambiq Micro, Inc. (NYSE:AMBQ) Given Average Rating of "Hold" by Brokerages

Shares of Ambiq Micro, Inc. (NYSE:AMBQ - Get Free Report) have earned an average recommendation of "Hold" from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports...

Ambiq Micro, Inc. (NYSE:AMBQ) Short Interest Update

Ambiq Micro, Inc. (NYSE:AMBQ - Get Free Report) saw a large decline in short interest in the month of February. As of February 27th, there was short interest totaling 151,605 shares, a decline of...

Ambiq Micro (NYSE:AMBQ) Shares Down 7.7% - Here's Why

Ambiq Micro (NYSE:AMBQ) Trading Down 7.7% - What's Next...

Ambiq Micro (NYSE:AMBQ) Releases Quarterly Earnings Results, Beats Expectations By $0.12 EPS

Ambiq Micro (NYSE:AMBQ - Get Free Report) released its quarterly earnings data on Thursday. The company reported ($0.49) earnings per share for the quarter, topping the consensus estimate of ($0.61...

Ambiq Micro Q4 Earnings Call Highlights

Ambiq Micro (NYSE:AMBQ) reported fourth-quarter and full-year fiscal 2025 results that management said reflected accelerating demand for edge AI, improved business mix, and benefits from the...

Ambiq Micro (NYSE:AMBQ) Shares Gap Up - Here's Why

Ambiq Micro (NYSE:AMBQ) Shares Gap Up - What's Next...

Ambiq Micro (AMBQ) Q4 2025 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Ambiq Micro, Inc. engages in the provision of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI computing. It operates through the following geographical segments: China, Taiwan, Singapore, and Rest of the World. The company was founded by Scott Hanson, Dennis Sylvester, and David Blaauw on January 20, 2010 and is headquartered in Austin, TX.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.35	--	--	N/A
Q4 '25	-$0.38	-$0.32	16.53%	BEAT
Q3 '25	-$0.33	-$0.22	33.24%	BEAT
Q2 '25	-$0.44	-$0.43	2.60%	BEAT

AMBQ
Ambiq Micro, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest AMBQ News

AMBQAmbiq Micro, Inc.